OrphanDrug
OrphanDrug
Pharma Knowledge Base

lymphangioleiomyomatosis

MeSH: D018192ORPHA: 538

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

rare interstitial and degenerative lung disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with lymphangioleiomyomatosis, sourced from HPO and Orphanet clinical annotations.

Abnormal morphology of female internal genitaliaHydrocephalusOptic atrophyHematuriaAbnormality of skin pigmentationLymphedemaSeizureAscitesFeverAbdominal painRestrictive ventilatory defectDyspneaEmphysemaHemoptysisPneumothoraxPulmonary infiltratesRecurrent respiratory infectionsGastrointestinal hemorrhageLymphadenopathyMultiple renal cystsRenal angiomyolipomaRetinal hamartomaShagreen patchRenal neoplasmChylothoraxChylopericardiumAbnormal urinary colorFatigueMaculeCoughPulmonary lymphangiomyomatosisCognitive impairmentChest painAtelectasisAbnormality of the lymphatic systemUngual fibroma

Classification & Codes

MeSH Code

D018192

Orphanet Code

ORPHA:538
lymphangioleiomyomatosis
MeSHD018192
OrphanetORPHA:538
Treatments0 drug(s)
Symptoms on record36 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO